基于TASC II膝下动脉分类的严重肢体缺血患者膝下介入治疗中期结局
单中心回顾性研究纳入166例严重肢体缺血患者、244处膝下病变,比较TASC A/B与C/D病变的结局。C/D组截肢率更高、主要不良肢体事件更多、一期通畅率更低,但3年生存率无差异。
要点
- TASC C/D膝下病变3年免截肢率67% vs A/B组85%。
- TASC C/D组3年免于主要不良肢体事件率61% vs A/B组79%。
- TASC A/B组技术成功率和1年一期通畅率更高。
核心结论
- TASC C/D膝下病变与更高的截肢率和主要不良肢体事件率相关,且一期通畅率低于TASC A/B病变。
研究设计与样本
- 单中心回顾性研究纳入2006至2013年166例连续严重肢体缺血患者(平均年龄71岁,113例男性),共244处膝下病变接受腔内治疗。
主要发现
- TASC A/B病变较短(53±35 vs 170±83 mm,p<0.001)、狭窄程度较轻(77%±24% vs 93%±14%,p<0.001)、靶血管直径较大(2.9±0.5 vs 2.6±0.5 mm,p<0.001),慢性完全闭塞较少(24% vs 64%,p<0.001)。
- TASC A/B组3年免截肢率(85% vs 67%,p=0.02)和免于主要不良肢体事件率(79% vs 61%,p=0.02)显著更高。
- TASC A/B组技术成功率(95% vs 80%,p<0.001)和1年一期通畅率(58% vs 51%,p=0.04)更高。
- 两组3年总生存率相似(96% vs 88%,p=0.2)。
关键数值与推荐
- 再狭窄定义为随访1、3、6、12个月时双功超声收缩期峰值流速比>2.0。
临床怎么用
- 对严重肢体缺血患者行膝下介入治疗时,TASC C/D病变需预期更高的截肢和主要不良肢体事件风险及更低一期通畅率。
局限性
- 单中心回顾性设计可能限制结论的外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the relationship between the new TransAtlantic Inter-Society Consensus (TASC II) infrapopliteal classification and limb outcomes among patients with critical limb ischemia (CLI). METHODS: A single-center retrospective study was performed on 166 consecutive CLI patients (mean age 71 years; 113 men) undergoing endovascular treatment of 244 infrapopliteal lesions from 2006 to 2013. Patient, procedural, angiographic, and limb outcomes were compared for the new TASC A/B vs C/D classification for infrapopliteal lesions. Binary restenosis was determined by a peak systolic velocity ratio >2.0 by duplex ultrasound on follow-up at 1, 3, 6, and 12 months. RESULTS: Seventy-two (43.4%) patients had TASC A/B lesions, while 94 (56.6%) had TASC C/D patterns of infrapopliteal disease. Baseline demographics and tissue loss (93% vs 94%, p=0.59) were similar between the groups. TASC A/B lesions were shorter (53±35 vs 170±83 mm, p<0.001), less severely stenosed (77%±24% vs 93%±14%, p<0.001), had a larger target vessel diameter (2.9±0.5 vs 2.6±0.5 mm, p<0.001), and were less frequently chronic total occlusions (24% vs 64%, p<0.001) compared with the TASC C/D group. Three-year freedom from both amputation (85% vs 67%, p=0.02) and major adverse limb events (79% vs 61%, p=0.02) were significantly higher in the TASC A/B group. Technical success rates (95% vs 80%, p<0.001) and 1-year primary patency (58% vs 51%, p=0.04) were higher in the A/B group. Overall 3-year survival was similar between the groups (96% A/B vs 88% C/D, p=0.2). CONCLUSION: TASC C/D infrapopliteal lesions are associated with higher amputation and major adverse limb events rates and lower primary patency compared with TASC A/B infrapopliteal lesions. Further studies are needed to assess the association between TASC C/D infrapopliteal lesions and clinical outcomes in patients with CLI.
引用
- Singh GD, Brinza EK, Hildebrand J, et al. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries. J Endovasc Ther. 2017. PMID: 28421855. doi:10.1177/1526602817704643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。